The ultrastructure of lymphocytes in schizophrenia

References

• Arolt V, Rothermundt M, Wandinger KP, Kirchner H. Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment. Mol Psychiatry 2000; 5: 150–158
   PubMed Web of Science ®Google Scholar
• Androsova LV, Sekirina TP, Kushner SG, Abramova LI, Kaleda VG, Kolyaskina GI. Interleukine system in individuals with schizophrenia. Zh Nevrol Psikhiatr Im SS Korsakova :2 2004; 104: 43–47
   Google Scholar
• Brier A, Berg PH. The psychosis of schizophrenia: prevalence response to atypical antidepressants and prediction of outcome. Biol Psychiatry 1999; 46: 362–364
   Google Scholar
• Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Ruslanova I, Yolken RH. Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. Arch Gen Psychiatry 2003; 60: 466–472
   PubMed Web of Science ®Google Scholar
• Fessel WJ, Hirata-Hibi M. Abnormal leukocytes in schizophrenia. Arch Gen Psychiatry 1963; 9: 601–613
   PubMed Web of Science ®Google Scholar
• Ganguli R, Brar JS, Solomon W, Chengappa KN, Rabin BS. Altered interleukin-2 production in schizophrenia: association between clinical state and autoantibody production. Psychiatry Res 1992; 44: 113–123
   PubMed Web of Science ®Google Scholar
• Ganguli R, Brar JS, Cengappa KN, Yang ZW, Nimgaonkar VL, Rabin BS. Autoimmunity in schizophrenia: a review of recent findings. Ann Med 1993; 25: 489–496
   PubMed Web of Science ®Google Scholar
• Ganguli R, Brar JS, Rabin BS. Immune abnormalities in schizophrenia: evidence for the autoimmune hypothesis. Harv Rev Psychiatry 1994; 2: 70–83
   PubMed Web of Science ®Google Scholar
• Garver DL, Tamas RL, Holcomb JM. Elevated interleukin-6 in the cerebrospinal fluid of a previously delineated schizophrenia subtype. Neuropsychopharmacology 2003; 28: 1515–1520
   PubMed Web of Science ®Google Scholar
• Gladkevich A, Kauffman HF, Jakob K. 2004. Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 28:559–576.
   PubMed Web of Science ®Google Scholar
• Gundersen HJG, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JL, Pakkenberg B. The new stereological tools: Disector, Fractionator, nucleator and point sampled intersepts and their use in pathological research and diagnosis. Acta Pathol Microbiol Immunol Scand 1988; 96: 857–881
   PubMedGoogle Scholar
• Hirata-Hibi M, Hayashi K. The anatomy of the P lymphocyte. Schizophr Res 1992; 8: 257–262
   Web of Science ®Google Scholar
• Hirata-Hibi M, Higashi S, Tachibana T, Watanabe N. Stimulated lymphocytes in schizophrenia. Arch Gen Psychiatry 1982; 39: 82–87
   PubMedGoogle Scholar
• Hirata-Hibi M, Motow O, Miyauchi K, Tachibana T. Evidence of lymphocyte abnormality in schizophrenia. Viruses. immunity and mental disorders, E Kurstak, ZJ Lipowski, PV Morozov. Plenum Publishing Corporation, New York 1987; 327–341
   Google Scholar
• Kamp HV. Nuclear changes in the white blood cells of patients with schizophrenic reaction: preliminary report. J Neuropsychiatry 1962; 4: 1–3
   PubMedGoogle Scholar
• Karlsson H, Bachman S, Schrider J, McArthur J, Torrey EF, Yolken RH. Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia. Proc Natl Acad Sci USA 2001; 98: 4634–4639
   PubMed Web of Science ®Google Scholar
• Karlsson H, Schroder J, Bachmann S, Bottmer C, Yolken RH. HERV-W-related RNA detected in plasma from individuals with recent-onset schizophrenia or schizoaffective disorder. Mol Psychiatry 2004; 9: 12–13
   PubMed Web of Science ®Google Scholar
• Karry R, Klein E, Ben Shachar D. Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study. Biol Psychiatry 2004; 55: 676–684
   PubMed Web of Science ®Google Scholar
• Kay SP, Opler LA, Fiszbein A. Positive and Negative Syndrome Scale (PANSS) manual. Multi-Health Systems Inc, North Tonawanda, NY 1986
   Google Scholar
• Kokai M, Morita Y, Fukuda H, Hatotani N. Immunophenotypic studies on atypical lymphocytes in psychiatric patients. Psychiatry Res 1998; 77: 105–112
   PubMed Web of Science ®Google Scholar
• Kolyaskina GI, Sekirina TP, Androsova LV, Kushner SG, Vasilyeva EF, Burbaeva OA, Morozova MA. A change of immune profile of patients with schizophrenia during treatment. Zh Nevrol Psikhiatr Im SS Korsakova 2004; 104: 39–45
   Google Scholar
• Kung L, Roberts RC. Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study. Synapse 1999; 31: 67–75
   PubMed Web of Science ®Google Scholar
• Maurer I, Zierz S, Moller H. Evidence for a mitochondrial oxidative phophorylation defect in brains from patients with schizophrenia. Schizophr Res 2001; 48: 125–136
   PubMed Web of Science ®Google Scholar
• Muller N, Riedel M, Gruber R, Ackenheil M, Schwarz MJ. The immune system and schizophrenia. An integrative view. Ann NY Acad Sci 2000; 917: 456–467
   PubMed Web of Science ®Google Scholar
• Nikkila HV, Muller K, Ahokas A, Rimon R, Andersson LC. Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia. Schizophr Res 2001; 49: 99–105
   PubMed Web of Science ®Google Scholar
• Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL, Wayland M, Freeman T, Dudbridge F, Lilley KS, Karp NA, Hester S, Tkachev D, Mimmack ML, Yolken RH, Webster MJ, Torrey EF, Bahn S. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 2004; 9: 684–97. 643
   PubMed Web of Science ®Google Scholar
• Rudolf S, Schlenke P, Brooks A, Peters M, Rothermundt M, Arolt V, Kirchner H. Search for atypical lymphocytes in schizophrenia. World J Biol Psychiatry 2004; 5: 33–37
   PubMed Web of Science ®Google Scholar
• Schwartz M, Silver H. Lymphocytes autoantibodies and psychosis – coincidence versus etiological factor: an update Isr J Psychiatry Relat Sci 2000; 37: 32–36
   Google Scholar
• Siegel S, Castellan NJ. Nonparametric statistics for the behavioral sciences2nd ed. McGraw-Hill, New York 1988
   Google Scholar
• Sinyakov MS, Kessler B, Karp L, Weizman A, Kessler AR. Platelet-associated antibodies mediate protective autoimmune response in schizophrenia. Neuropsychobiology 2003; 48: 41–46
   PubMed Web of Science ®Google Scholar
• Sirota P, Firer MA, Shild K, Tanay A, Elizur A, Meytes D. Autoantibodies to DNA in multicase families with schizophrenia. Biol Psychiatry 1993; 33: 450–455
   PubMed Web of Science ®Google Scholar
• Sleasman JW. The association between immunodeficiency and the development of autoimmune disease. Adv Dent Res 1996; 10: 57–61
   PubMedGoogle Scholar
• Spitzer RL, Endicott J, Robins E. Research diagnostic criteria for a selected group of functional disorders3rd ed. New York State Psychiatric Institute, New York 1977
   Google Scholar
• Spivak B, Radwan M, Bartur P, Mester R, Weizman A. Antinuclear autoantibodies in chronic schizophrenia. Acta Psychatr Scand 1995; 92: 266–269
   PubMedGoogle Scholar
• Tanaka S, Matsunaga H, Kimura M, Tatsumi K, Hidaka Y, Takano T, Uema T, Takeda M, Amino N. Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders. J Neuroimmunol 2003; 141: 155–164
   PubMed Web of Science ®Google Scholar
• Theodoropoulou S, Spanakos G, Baxevanis CN, Economou M, Gritzapis AD, Papamichail MP, Stefanis SN. Cytokine serum levels. autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients. Schizophr Res 2001; 47: 13–25
   PubMed Web of Science ®Google Scholar
• Torrey EF, Upshaw YD, Suddath R. Medication effect on lymphocyte morphology in schizophrenia. Schizophr Res 1989; 2: 385–390
   PubMed Web of Science ®Google Scholar
• Uranova NA, Casanova MF, DeVaughn NM, Orlovskaya DD, Denisov DV. Ultrastructural alterations of synaptic contacts and astrocytes in postmortem caudate nucleus of schizophrenic patients. Letter to the Editor. Schizophr Res 1996; 22: 81–83
   PubMed Web of Science ®Google Scholar
• Uranova NA, Orlovskaya DD, Zimina IS, Vikhreva OV, Rachmanova VI, Klintsova AY, Black JE, Greenough WT. 2000. Decreased synaptic size in schizophrenic cortex: a postmortem morphometric electron microscopic study. Soc Neurosci 26.580.2.1558 [Abstract].
   Google Scholar
• Uranova N, Orlovskaya D, Vikhreva O, Zimina I, Kolomeets N, Vostrikov V, Rachmanova VI. Electron microscopic study of oligodendroglia in severe mental illness. Brain Res Bull 2001; 55(5)597–610
   PubMed Web of Science ®Google Scholar
• Uranova NA (2003) , Orlovskaya DD, Zimina IS, Vikhreva OV, Rachmanova VI, Klintsova AY, Black JE, Greenough WT. 2003. Ultrastructural pathology of myelinated fibers in schizophrenia: a morphometric study of prefrontal and visual cortex. Schizophr Res Abstracts of the IXth International Congress on schizophrenia research. Colorado Springs, , CO, 29 March–2 April . 60.1. p 76.
   Google Scholar
• Whatley SA, Curti D, Das Gupta F, Ferrier IN, Jones S, Taylor C, Marchbanks RM. Superoxide, neuroleptics and the ubiquinone and cytochrome b5 reductases in brain and lymphocytes from normals and schizophrenic patients. Mol Psychiatry 1998; 3: 227–237
   Google Scholar
• Yolken R. Viruses and schizophrenia: a focus on herpes simplex virus. Herpes 2004; 11(Suppl 2)83–88A
   Google Scholar
• Zhang XY, Zhou DF, Zhang PY, Wu GY, Cao LY, Shen YC. Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology. Schizophr Res 2002; 57: 247–258
   PubMed Web of Science ®Google Scholar
• Zucker-Franklin D, Greaves MF, Grossi CE. 1988. Atlas of blood cells: Function and pathology. Vol. II. 2nd ed. Milan: E.E. Ermes/Philadelphia, PA: Lea and Febiger.
   Google Scholar